MENU
ALXN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alexion Pharmaceuticals (ALXN) Ownership - Who owns Alexion Pharmaceuticals?

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Miscellaneous
Capitalization
36.6B
P/E Ratio
59.17
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
6.26B
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
4.88
Revenue/Share
28.21 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of biologic therapeutic products

Industry NotClassified

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A